A
Armando Santoro
Researcher at Humanitas University
Publications - 961
Citations - 56759
Armando Santoro is an academic researcher from Humanitas University. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 93, co-authored 847 publications receiving 48505 citations. Previous affiliations of Armando Santoro include Aix-Marseille University & University of Milan.
Papers
More filters
Journal ArticleDOI
Lung resection as salvage treatment for metastatic osteosarcoma.
Ugo Pastorino,Maurizio Valente,Marco Gasparini,Alberto Azzarelli,Armando Santoro,Luca Tavecchio,Marco Alloisio,Mauro Ongari,Gianni Ravasi +8 more
TL;DR: The results of surgical management of 27 consecutive cases of pulmonary metastases from osteosarcoma, who underwent complete resection at the Istituto Nazionale Tumori of Milan between 1975 and 1986, support the concept ofmonary metastasectomy as effective salvage therapy for metastatic osteosARcomas whose distant spread is confined in the lungs.
Journal ArticleDOI
Pembrolizumab for previously treated advanced anal squamous cell carcinoma: results from the non-randomised, multicohort, multicentre, phase 2 KEYNOTE-158 study.
Aurélien Marabelle,Philippe A. Cassier,Marwan Fakih,Steven Kao,Dorte Nielsen,Antoine Italiano,Tormod Kyrre Guren,M. G. J. van Dongen,Kristen Spencer,Giovanni M. Bariani,Paolo A. Ascierto,Armando Santoro,Manisha H. Shah,Jamil Asselah,Syma Iqbal,T. Takahashi,Sarina Anne Piha-Paul,Patrick A. Ott,Arkendu Chatterjee,Fan Jin,Kevin Norwood,Jean-Pierre Delord +21 more
TL;DR: Pembrolizumab monotherapy is a possible treatment option with a favourable benefit-risk ratio for patients with previously treated advanced anal squamous cell carcinoma who have no alternative satisfactory treatment options.
Journal ArticleDOI
Factors predicting outcome after allogeneic transplant in refractory acute myeloid leukemia: a retrospective analysis of Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
Elisabetta Todisco,Fabio Ciceri,Cristina Boschini,Fabio Giglio,Andrea Bacigalupo,Francesca Patriarca,Irene Donnini,Emilio Paolo Alessandrino,William Arcese,A. P. Iori,Paola Marenco,Irene Cavattoni,Patrizia Chiusolo,Elisabetta Terruzzi,L. Castagna,Armando Santoro,Alberto Bosi,Elena Oldani,Bénédicte Bruno,Francesca Bonifazi,Alessandro Rambaldi +20 more
TL;DR: The identification of pre-HSCT variables may help to determine PRF AML patients who can most likely benefit from HSCT, and set up a new score predicting at 3 years after transplantation, an overall survival probability of 32% for patients with score 0 (no or 1 prognostic factor).
Journal ArticleDOI
Vertebroplasty for pain relief and spinal stabilization in multiple myeloma
Flavio Tancioni,Martin A. Lorenzetti,Pierina Navarria,Andrea Nozza,Luca Castagna,Paolo Gaetani,E. Aimar,Daniel Levi,Antonio Di Ieva,Patrizia Pisano,Armando Santoro,Marta Scorsetti,Riccardo Rodriguez y Baena +12 more
TL;DR: Vertebroplasty is a safe and efficient procedure in the treatment of painful vertebral body fractures in patients with multiple myeloma, without potential contraindications, such as fractures of the posterior wall or epidural disease.
Journal ArticleDOI
Randomized phase III trial comparing infused 5-fluorouracil/folinic acid (LV5FU) versus LV5FU+irinotecan (LV5FU+IRI) as adjuvant treatment after complete resection of liver metastases from colorectal cancer (LMCRC). (CPT-GMA-301)
M. Ychou,Werner Hohenberger,S. Thezenas,Matilde Navarro,P. Gascon,Carsten Bokemeyer,E. Shacham-Shmueli,Fernando Rivera,C. Kwok-Keung Choi,Armando Santoro +9 more
TL;DR: The aim of this international, randomized trial was to compare the adjunction of IRI to FUFA in this setting and showed improvement in outcome of advanced colorectal cancer.